| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.08. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| ZHONGCHAO Aktie jetzt für 0€ handeln | |||||
| 23.07. | Morning Market Movers: 707 Cayman, Zhongchao, NVE Corporation, Medpace See Big Swings | 1.254 | AFX News | BEIJING (dpa-AFX) - At 8:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 22.07. | Zhongchao Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 03.07. | Zhongchao Stock Surges 200% After Hours: Here's Why | 16 | Benzinga.com | ||
| 25.06. | Zhongchao announces 1-for-3 share consolidation | 1 | Seeking Alpha | ||
| 25.06. | Zhongchao kündigt Aktienzusammenlegung im Verhältnis 1:3 an | 7 | Investing.com Deutsch | ||
| 25.06. | Zhongchao announces 1-for-3 reverse stock split effective Sunday | 2 | Investing.com | ||
| 25.06. | Zhongchao Inc. Announces 1-for-3 Share Consolidation | 450 | PR Newswire | SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 23.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | Zhongchao führt am Sonntag Reverse-Aktiensplit im Verhältnis 1:31 durch | 1 | Investing.com Deutsch | ||
| 04.06. | Zhongchao Inc. Announces 1-for-31 Share Consolidation | 247 | PR Newswire | SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 29.05. | Zhongchao prices $5 million public offering at $0.54 per unit | 18 | Investing.com | ||
| 29.05. | Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering | 234 | PR Newswire | SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services... ► Artikel lesen | |
| 22.05. | Zhongchao Inc. - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 07.05. | Zhongchao Inc. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 03.04. | Zhongchao Inc. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 18.03. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.02. | Zhongchao announces 1-for-8 share consolidation | 2 | Seeking Alpha | ||
| 26.02. | Zhongchao Inc. Announces 1-for-8 Share Consolidation | 226 | PR Newswire | SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,650 | +1,26 % | Eckert & Ziegler: Radiopharmaka als Wachstumsbooster in herausfordernden Zeiten | ||
| SERNOVA BIOTHERAPEUTICS | 0,069 | +1,46 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
10.08.2026 / 09:00 CET/CEST
The... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | 0,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,059 | 0,00 % | UniDoc Health Corp.: UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform | Proposed collaboration would combine UniDoc's connected-care infrastructure with Ventripoint's AI-enabled cardiac imaging platform VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,210 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUEST DIAGNOSTICS | 208,80 | -0,24 % | ROUNDUP: Quest Diagnostics Boosts FY26 Outlook; Shares Up 5.7% | WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Thursday, diagnostic services firm Quest Diagnostics, Inc. (DGX) raised its earnings, adjusted earnings and... ► Artikel lesen | |
| QUIDELORTHO | 11,850 | -6,10 % | QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns | ||
| VERU | 2,640 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 7,420 | +1,37 % | H.C. Wainwright reiterates Lifeward stock rating on revenue growth | ||
| SENSEONICS | 8,250 | -0,60 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 1,040 | 0,00 % | Tempest Therapeutics, Inc. - S-1, General form for registration of securities |